Original article
Are oral cefuroxime axetil, cefixime and cefditoren pivoxil adequate to treat uncomplicated acute pyelonephritis after switching from intravenous therapy? A pharmacokinetic/pharmacodynamic perspective
Cefuroxima axetilo, cefixima y cefditoren pivoxil, ¿son adecuadas en la terapia secuencial de la pielonefritis aguda no complicada? Perspectiva farmacocinética y farmacodinámica
Read
3347
Timeswas read the article
941
Total PDF
2406
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 December | 34 | 31 | 65 |
| 2024 November | 40 | 29 | 69 |
| 2024 October | 30 | 29 | 59 |
| 2024 September | 41 | 35 | 76 |
| 2024 August | 32 | 29 | 61 |
| 2024 July | 20 | 36 | 56 |
| 2024 June | 33 | 26 | 59 |
| 2024 May | 48 | 22 | 70 |
| 2024 April | 31 | 51 | 82 |
| 2024 March | 67 | 32 | 99 |
| 2024 February | 51 | 42 | 93 |
| 2024 January | 64 | 45 | 109 |
| 2023 December | 62 | 38 | 100 |
| 2023 November | 73 | 29 | 102 |
| 2023 October | 107 | 35 | 142 |
| 2023 September | 89 | 39 | 128 |
| 2023 August | 69 | 23 | 92 |
| 2023 July | 71 | 27 | 98 |
| 2023 June | 40 | 20 | 60 |
| 2023 May | 124 | 54 | 178 |
| 2023 April | 93 | 24 | 117 |
| 2023 March | 93 | 12 | 105 |
| 2023 February | 43 | 12 | 55 |
| 2023 January | 47 | 12 | 59 |
| 2022 December | 44 | 13 | 57 |
| 2022 November | 41 | 8 | 49 |
| 2022 October | 35 | 15 | 50 |
| 2022 September | 44 | 17 | 61 |
| 2022 August | 49 | 7 | 56 |
| 2022 July | 32 | 9 | 41 |
| 2022 June | 36 | 6 | 42 |
| 2022 May | 62 | 13 | 75 |
| 2022 April | 39 | 15 | 54 |
| 2022 March | 72 | 11 | 83 |
| 2022 February | 51 | 7 | 58 |
| 2022 January | 93 | 4 | 97 |
| 2021 December | 48 | 8 | 56 |
| 2021 November | 51 | 17 | 68 |
| 2021 October | 64 | 8 | 72 |
| 2021 September | 57 | 6 | 63 |
| 2021 August | 46 | 6 | 52 |
| 2021 July | 33 | 5 | 38 |
| 2021 June | 19 | 6 | 25 |
| 2021 May | 23 | 8 | 31 |
| 2021 April | 36 | 7 | 43 |
| 2021 March | 19 | 3 | 22 |
| 2021 February | 10 | 10 | 20 |
Show all
